Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Expectoration | Case report

Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report

Authors: Ancong Xu, Hong Zhu, Bingqi Gao, Haixu Weng, Zhangna Ding, Mianmian Li, Xing Weng, Guoxin He

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Acinetobacter baumannii is a gram-negative aerobic bacillus that is commonly causes of hospital-acquired infections. Community-acquired pneumonia caused by Acinetobacter baumannii (CAP-Ab) is rare but fatal if diagnosis and treatment are delayed. Conventional culture of clinical specimens is the main method for clinical diagnosis of A. baumannii infections which may suffer from limited positive rate and is time consuming. Timely and precise diagnosis of CAP-Ab remains challenging.

Case presentation

A 66-year-old man with 24 h history of acute fever and dyspnea was admitted to our hospital. He was diagnosed as severe community acquired pneumonia (CAP), septic shock, respiratory failure and acute kidney injury. Next-generation sequencing (NGS) was performed on the patient’s sputum and blood, which identified numerous A. baumannii nucleotide sequences in the sample of sputum and led to the rapid diagnosis and treatment of community acquired pneumonia caused by A. baumannii. This result was confirmed by subsequent sputum culture.

Conclusions

This case described that the successful application of the next generation sequencing assisting the speedy diagnosis of A. baumannii infection provides a new idea for the timely diagnosis of CAP-Ab and highlights that NGS is a promising tool in rapid etiological diagnosis of acute and severe infectious diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–9.CrossRef Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–9.CrossRef
2.
go back to reference Garnacho-Montero J, Timsit JF. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis. 2019;32(1):69–76.CrossRef Garnacho-Montero J, Timsit JF. Managing Acinetobacter baumannii infections. Curr Opin Infect Dis. 2019;32(1):69–76.CrossRef
3.
go back to reference Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271–81.CrossRef Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271–81.CrossRef
4.
go back to reference Peleg AY, de Breij A, Adams MD, et al. The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS One. 2012;7(10):e46984.CrossRef Peleg AY, de Breij A, Adams MD, et al. The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS One. 2012;7(10):e46984.CrossRef
5.
go back to reference Son YW, Jung IY, Ahn MY, et al. A case of community-acquired pneumonia caused by multidrug-resistant Acinetobacter baumannii in Korea. Infect Chemother. 2017;49(4):297–300.CrossRef Son YW, Jung IY, Ahn MY, et al. A case of community-acquired pneumonia caused by multidrug-resistant Acinetobacter baumannii in Korea. Infect Chemother. 2017;49(4):297–300.CrossRef
6.
go back to reference Iwasawa Y, Hosokawa N, Harada M, et al. Severe community-acquired pneumonia caused by Acinetobacter baumannii successfully treated with the initial Administration of Meropenem Based on the sputum gram staining findings. Intern Med. 2019;58(2):301–5.CrossRef Iwasawa Y, Hosokawa N, Harada M, et al. Severe community-acquired pneumonia caused by Acinetobacter baumannii successfully treated with the initial Administration of Meropenem Based on the sputum gram staining findings. Intern Med. 2019;58(2):301–5.CrossRef
7.
go back to reference Serota DP, Sexton ME, Kraft CS, et al. Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature. Open Forum Infect Dis. 2018;5(3):ofy044.CrossRef Serota DP, Sexton ME, Kraft CS, et al. Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature. Open Forum Infect Dis. 2018;5(3):ofy044.CrossRef
8.
go back to reference Falagas ME, Karveli EA, Kelesidis I, et al. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007;26(12):857–68.CrossRef Falagas ME, Karveli EA, Kelesidis I, et al. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis. 2007;26(12):857–68.CrossRef
9.
go back to reference Kang SJ, Kang CI, Park SY, et al. Epidemiology and clinical features of community-onset Acinetobacter baumannii infections. Infect Control Hosp Epidemiol. 2012;33(10):1053–5.CrossRef Kang SJ, Kang CI, Park SY, et al. Epidemiology and clinical features of community-onset Acinetobacter baumannii infections. Infect Control Hosp Epidemiol. 2012;33(10):1053–5.CrossRef
10.
go back to reference Dexter C, Murray GL, Paulsen IT, et al. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti-Infect Ther. 2015;13(5):567–73.CrossRef Dexter C, Murray GL, Paulsen IT, et al. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti-Infect Ther. 2015;13(5):567–73.CrossRef
11.
go back to reference Leung WS, Chu CM, Tsang KY, et al. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest. 2006;129(1):102–9.CrossRef Leung WS, Chu CM, Tsang KY, et al. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest. 2006;129(1):102–9.CrossRef
12.
go back to reference Davis JS, McMillan M, Swaminathan A, et al. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Chest. 2014;146(4):1038–45.CrossRef Davis JS, McMillan M, Swaminathan A, et al. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Chest. 2014;146(4):1038–45.CrossRef
13.
go back to reference Mohd R, Nesam T, Kamaruzaman L, et al. Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia - a case report. Respir Med Case Rep. 2018;24:147–9.PubMedPubMedCentral Mohd R, Nesam T, Kamaruzaman L, et al. Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia - a case report. Respir Med Case Rep. 2018;24:147–9.PubMedPubMedCentral
14.
go back to reference Ni PX, Ding X, Zhang YX, et al. Rapid detection and identification of infectious pathogens based on high-throughput sequencing. Chin Med J. 2015;128(7):877–83.CrossRef Ni PX, Ding X, Zhang YX, et al. Rapid detection and identification of infectious pathogens based on high-throughput sequencing. Chin Med J. 2015;128(7):877–83.CrossRef
15.
go back to reference Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408–17.CrossRef Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408–17.CrossRef
16.
go back to reference Thorburn F, Bennett S, Modha S, et al. The use of next generation sequencing in the diagnosis and typing of respiratory infections. J Clin Virol. 2015;69:96–100.CrossRef Thorburn F, Bennett S, Modha S, et al. The use of next generation sequencing in the diagnosis and typing of respiratory infections. J Clin Virol. 2015;69:96–100.CrossRef
17.
go back to reference Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8(1):73.CrossRef Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8(1):73.CrossRef
18.
go back to reference Zhu YM, Ai JW, Xu B, et al. Rapid and precise diagnosis of disseminated T.marneffei infection assisted by high-throughput sequencing of multifarious specimens in a HIV-negative patient: a case report. BMC Infect Dis. 2018;18(1):379.CrossRef Zhu YM, Ai JW, Xu B, et al. Rapid and precise diagnosis of disseminated T.marneffei infection assisted by high-throughput sequencing of multifarious specimens in a HIV-negative patient: a case report. BMC Infect Dis. 2018;18(1):379.CrossRef
Metadata
Title
Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report
Authors
Ancong Xu
Hong Zhu
Bingqi Gao
Haixu Weng
Zhangna Ding
Mianmian Li
Xing Weng
Guoxin He
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4733-5

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.